Related references
Note: Only part of the references are listed.Role of Adaptor Molecule Gab2 in Mast Cell-mediated Allergy Response
Keigo Nishida
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
Bryan D. White et al.
GASTROENTEROLOGY (2012)
Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells
Y. Wang et al.
ONCOGENE (2012)
Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors
P. C. Lara et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
M. J. Duffy et al.
ANNALS OF ONCOLOGY (2010)
Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis
Sergio Iadevaia et al.
CANCER RESEARCH (2010)
Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development
Emmy D. G. Fleuren et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease
Xiao-Ling Pan et al.
NEUROSCIENCE BULLETIN (2010)
Gab2-Mediated Signaling Promotes Melanoma Metastasis
Basil Horst et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Oncogenic Function of ATDC in Pancreatic Cancer through Wnt Pathway Activation and β-Catenin Stabilization
Lidong Wang et al.
CANCER CELL (2009)
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Huadong Pei et al.
CANCER CELL (2009)
Function, regulation and pathological roles of the Gab/DOS docking proteins
Franziska U. Woehrle et al.
CELL COMMUNICATION AND SIGNALING (2009)
A Wnt Survival Guide: From Flies to Human Disease
Andy J. Chien et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model
M. Niedergethmann et al.
BRITISH JOURNAL OF CANCER (2007)
Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma
Marina Pasca di Magliano et al.
PLOS ONE (2007)
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
Asma Sultana et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Increased expression of Gab2, a scaffolding adaptor of the tyrosine kinase signalling, in gastric carcinomas
Sung Hak Lee et al.
PATHOLOGY (2007)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
GAB2 is a novel target of 11q amplification in AML/MDS
Andrea Zatkova et al.
GENES CHROMOSOMES & CANCER (2006)
Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin γ-2 chain is an early coordinated event in incipient oral squamous cell carcinoma
P Lindberg et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway
Garth Powis et al.
CLINICAL CANCER RESEARCH (2006)
Aberrant Wnt/β-catenin signaling in pancreatic adenocarcinoma
Gang Zeng et al.
NEOPLASIA (2006)
Urokinase system expression in gastric carcinoma - Prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens
BCM Beyer et al.
CANCER (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
The Akt/PKB pathway: molecular target for cancer drug discovery
JQ Cheng et al.
ONCOGENE (2005)
Molecular prognostic markers in pancreatic cancer: A systematic review
G Garcea et al.
EUROPEAN JOURNAL OF CANCER (2005)
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
M Reni et al.
LANCET ONCOLOGY (2005)
Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value
B Hundsdorfer et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2005)
Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate
CMR Lima et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry
JJ Shen et al.
CANCER RESEARCH (2004)
Open source clustering software
MJL de Hoon et al.
BIOINFORMATICS (2004)
Proteomic applications for the early detection of cancer
JD Wulfkuhle et al.
NATURE REVIEWS CANCER (2003)
The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors
K Nishida et al.
CANCER SCIENCE (2003)
The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer
RJ Daly et al.
ONCOGENE (2002)
New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway
HH Gu et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
